tiprankstipranks
Predilife SA (FR:ALPRE)
:ALPRE
France Market

Predilife SA (ALPRE) Price & Analysis

0 Followers

ALPRE Stock Chart & Stats

€3.20
€0.48(13.71%)
At close: 4:00 PM EST
€3.20
€0.48(13.71%)

ALPRE FAQ

What was Predilife SA’s price range in the past 12 months?
Predilife SA lowest stock price was €0.90 and its highest was €4.00 in the past 12 months.
    What is Predilife SA’s market cap?
    Predilife SA’s market cap is €3.74M.
      When is Predilife SA’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Predilife SA’s earnings last quarter?
      Currently, no data Available
      Is Predilife SA overvalued?
      According to Wall Street analysts Predilife SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Predilife SA pay dividends?
        Predilife SA does not currently pay dividends.
        What is Predilife SA’s EPS estimate?
        Predilife SA’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Predilife SA have?
        Predilife SA has 3,952,233 shares outstanding.
          What happened to Predilife SA’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Predilife SA?
          Currently, no hedge funds are holding shares in FR:ALPRE
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Predilife SA

            Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare solutions and comprehensive breast screening tests. Among its notable products are MammoRisk, a diagnostic tool designed to forecast an individual's risk of developing breast cancer; DenSeeMammo, software for evaluating breast tissue density; and a specialized medical device developed for predicting prostate cancer risk.
            Similar Stocks
            Company
            Price & Change
            Follow
            Novacyt
            Eurobio-Scientific SA
            Eurofins-Cerep SA
            Biosynex SA
            ABL Diagnostics SA
            Popular Stocks